Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 297

1.
2.

The effect of intravenous haloperidol on QT interval dispersion in critically ill patients: comparison with QT interval prolongation for assessment of risk of Torsades de Pointes.

Tisdale JE, Rasty S, Padhi ID, Sharma ND, Rosman H.

J Clin Pharmacol. 2001 Dec;41(12):1310-8. Erratum in: J Clin Pharmacol 2002 May;42(5):577-9.

PMID:
11762558
3.
4.

Antipsychotic-related QTc prolongation, torsade de pointes and sudden death.

Haddad PM, Anderson IM.

Drugs. 2002;62(11):1649-71. Review.

PMID:
12109926
5.

Prolonged cardiac repolarization after tacrolimus and haloperidol administration in the critically ill patient.

Akers WS, Flynn JD, Davis GA, Green AE, Winstead PS, Strobel G.

Pharmacotherapy. 2004 Mar;24(3):404-8.

PMID:
15040655
6.

Proarrhythmic risk with antipsychotic and antidepressant drugs: implications in the elderly.

Vieweg WV, Wood MA, Fernandez A, Beatty-Brooks M, Hasnain M, Pandurangi AK.

Drugs Aging. 2009;26(12):997-1012. doi: 10.2165/11318880-000000000-00000. Review.

PMID:
19929028
7.

Examination of baseline risk factors for QTc interval prolongation in patients prescribed intravenous haloperidol.

Muzyk AJ, Rayfield A, Revollo JY, Heinz H, Gagliardi JP.

Drug Saf. 2012 Jul 1;35(7):547-53. doi: 10.2165/11599960-000000000-00000.

PMID:
22702639
8.

[Minimizing the risks associated with QTc prolongation in people with schizophrenia. A consensus statement by the Cardiac Safety in Schizophrenia Group].

Ames D, Camm J, Cook P, Falkai P, Gury C, Hurley R, Johnson G, Piepho R, Vieweg V; Cardiac Safety in Schizophrenia Group.

Encephale. 2002 Nov-Dec;28(6 Pt 1):552-62. French.

PMID:
12506268
9.

Systematic review of antipsychotics for the treatment of hospital-associated delirium in medically or surgically ill patients.

Lacasse H, Perreault MM, Williamson DR.

Ann Pharmacother. 2006 Nov;40(11):1966-73. Epub 2006 Oct 17. Review.

PMID:
17047137
10.
11.

Torsades de Pointes associated with intravenous haloperidol in critically ill patients.

Sharma ND, Rosman HS, Padhi ID, Tisdale JE.

Am J Cardiol. 1998 Jan 15;81(2):238-40.

PMID:
9591913
12.

The association between intravenous haloperidol and prolonged QT interval.

Hatta K, Takahashi T, Nakamura H, Yamashiro H, Asukai N, Matsuzaki I, Yonezawa Y.

J Clin Psychopharmacol. 2001 Jun;21(3):257-61.

PMID:
11386487
13.

Long QT syndrome caused by noncardiac drugs.

Viskin S, Justo D, Halkin A, Zeltser D.

Prog Cardiovasc Dis. 2003 Mar-Apr;45(5):415-27. Review.

PMID:
12704598
14.

Sevoflurane causes greater QTc interval prolongation in elderly patients than in younger patients.

Nakao S, Hatano K, Sumi C, Masuzawa M, Sakamoto S, Ikeda S, Shingu K.

Anesth Analg. 2010 Mar 1;110(3):775-9. doi: 10.1213/ANE.0b013e3181cde713.

PMID:
20185656
15.

Torsade de pointes caused by high-dose intravenous haloperidol in cardiac patients.

Di Salvo TG, O'Gara PT.

Clin Cardiol. 1995 May;18(5):285-90. Review.

16.

A retrospective study of the safety of intramuscular ziprasidone in agitated elderly patients.

Greco KE, Tune LE, Brown FW, Van Horn WA.

J Clin Psychiatry. 2005 Jul;66(7):928-9.

PMID:
16013910
17.

Droperidol, QT prolongation, and sudden death: what is the evidence?

Kao LW, Kirk MA, Evers SJ, Rosenfeld SH.

Ann Emerg Med. 2003 Apr;41(4):546-58. Review.

PMID:
12658255
18.
19.
20.

Schizophrenia, antipsychotic drugs, and cardiovascular disease.

Glassman AH.

J Clin Psychiatry. 2005;66 Suppl 6:5-10. Review.

Supplemental Content

Support Center